
Radius Health RDUS
Quarterly report 2022-Q2
added 05-16-2026
Radius Health EBITDA per Share 2011-2026 | RDUS
Annual EBITDA per Share Radius Health
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.13 | -1.74 | -2.39 | -4.44 | -5.64 | -4.28 | -2.49 | -3.35 | -77 | -76.7 | -83 | -48.2 | -48.2 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.13 | -83 | -27.6 |
Quarterly EBITDA per Share Radius Health
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -0.15 | -0.28 | - | -0.35 | -0.24 | -0.28 | - | 0.05 | -0.78 | -0.67 | - | -0.5 | -0.63 | -0.81 | - | -0.95 | -1.4 | -1.27 | - | -1.23 | -1.57 | -1.33 | - | -1.07 | -1.02 | -0.95 | - | -0.64 | -0.59 | -0.45 | - | -0.56 | -1.82 | -30.7 | - | -19.5 | -20.3 | -21.7 | - | -18.7 | -19.5 | -15.4 | - | -14.9 | -36.1 | -15.6 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.05 | -36.1 | -6.63 |
EBITDA per Share of other stocks in the Drug manufacturers industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Endo International plc
ENDP
|
1.3 | - | - | $ 28.9 M | ||
|
Evoke Pharma
EVOK
|
-2.73 | - | - | $ 36.6 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
0.19 | $ 5.72 | -2.39 % | $ 85 M | ||
|
HEXO Corp.
HEXO
|
-2.75 | - | 2.45 % | $ 38.1 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
-6.95 | - | -0.1 % | $ 2.03 B | ||
|
AcelRx Pharmaceuticals
ACRX
|
-0.32 | - | 7.5 % | $ 6.35 M | ||
|
DURECT Corporation
DRRX
|
-0.61 | - | - | $ 50.1 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
-0.16 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
-0.86 | - | - | $ 754 M | ||
|
Agile Therapeutics
AGRX
|
-9.17 | - | 10.11 % | $ 58.2 M | ||
|
Alimera Sciences
ALIM
|
0.27 | - | - | $ 142 M | ||
|
Cronos Group
CRON
|
-0.01 | $ 2.79 | 0.72 % | $ 1.07 B | ||
|
Athenex
ATNX
|
-10 | - | -23.39 % | $ 1.76 M | ||
|
Harrow Health
HROW
|
0.87 | $ 33.46 | 1.09 % | $ 1.23 B | ||
|
Avadel Pharmaceuticals plc
AVDL
|
-0.42 | - | - | $ 2.06 B | ||
|
Catalent
CTLT
|
-1.44 | - | - | $ 11.5 B | ||
|
Organogenesis Holdings
ORGO
|
0.47 | $ 2.48 | 4.2 % | $ 314 M | ||
|
Eagle Pharmaceuticals
EGRX
|
6.31 | - | -39.89 % | $ 27.7 M | ||
|
Canopy Growth Corporation
CGC
|
-0.89 | $ 1.02 | - | $ 110 M | ||
|
Pacira BioSciences
PCRX
|
0.12 | $ 23.21 | 1.53 % | $ 1.07 B | ||
|
Sonoma Pharmaceuticals
SNOA
|
-2.88 | $ 1.11 | 1.83 % | $ 1.38 M | ||
|
Solid Biosciences
SLDB
|
-2.03 | $ 6.57 | 2.5 % | $ 575 M | ||
|
Aurora Cannabis
ACB
|
0.09 | $ 3.38 | -0.88 % | $ 185 M | ||
|
Jupiter Wellness
JUPW
|
0.16 | - | - | $ 33.6 M | ||
|
Lannett Company
LCI
|
-3.52 | - | 1.15 % | $ 7.11 M | ||
|
OrganiGram Holdings
OGI
|
-0.37 | $ 1.08 | 0.93 % | $ 103 M | ||
|
Tilray
TLRY
|
-2.22 | $ 5.17 | 2.78 % | $ 3.19 B | ||
|
Evolus
EOLS
|
-0.39 | $ 6.7 | 0.3 % | $ 432 M | ||
|
Sundial Growers
SNDL
|
-71 | $ 1.46 | 0.69 % | $ 3.37 M | ||
|
Emergent BioSolutions
EBS
|
3.66 | $ 7.95 | -0.63 % | $ 425 M | ||
|
Veru
VERU
|
-1.68 | $ 3.1 | 3.33 % | $ 45.4 M | ||
|
Neoleukin Therapeutics
NLTX
|
-4.7 | - | - | $ 193 M | ||
|
cbdMD
YCBD
|
-0.45 | $ 0.72 | -0.69 % | $ 2.9 M | ||
|
Assertio Holdings
ASRT
|
1.32 | $ 23.46 | 0.13 % | $ 150 M | ||
|
ProPhase Labs
PRPH
|
-1.56 | - | - | $ 5.07 M | ||
|
Bausch Health Companies
BHC
|
8.15 | $ 5.17 | 1.17 % | $ 1.92 B | ||
|
PetIQ
PETQ
|
2.8 | - | 1.64 % | $ 400 M | ||
|
Relmada Therapeutics
RLMD
|
-1.5 | $ 6.27 | 9.62 % | $ 248 M | ||
|
Recro Pharma
REPH
|
0.05 | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
-1.58 | - | - | $ 1.08 B | ||
|
SCYNEXIS
SCYX
|
-0.32 | $ 4.36 | -2.02 % | $ 218 M | ||
|
PLx Pharma
PLXP
|
-1.72 | - | -27.8 % | $ 2.56 M | ||
|
Viatris
VTRS
|
2.92 | $ 16.2 | 1.69 % | $ 18.9 B | ||
|
Zomedica Corp.
ZOM
|
-0.08 | - | -0.21 % | $ 98 M | ||
|
Zynerba Pharmaceuticals
ZYNE
|
-0.82 | - | - | $ 55.5 M | ||
|
Rockwell Medical
RMTI
|
-0.07 | $ 0.69 | 3.81 % | $ 24.8 M | ||
|
Tricida
TCDA
|
-2.97 | - | - | $ 3.25 M | ||
|
China Pharma Holdings
CPHI
|
-0.4 | $ 0.72 | 0.75 % | $ 3.09 M | ||
|
TherapeuticsMD
TXMD
|
-0.35 | $ 1.88 | - | $ 21.7 M |